TELCON RF PHARMACEUTICAL. Inc. (KOSDAQ:200230)

TELCON RF PHARMACEUTICAL. Statistics

Total Valuation

KOSDAQ:200230 has a market cap or net worth of KRW 43.72 billion. The enterprise value is 83.62 billion.

Market Cap	43.72B
Enterprise Value	83.62B

Important Dates

The last earnings date was Tuesday, August 12, 2025.

Earnings Date	Aug 12, 2025
Ex-Dividend Date	n/a

Share Statistics

KOSDAQ:200230 has 36.05 million shares outstanding. The number of shares has increased by 5.06% in one year.

Current Share Class	36.05M
Shares Outstanding	36.05M
Shares Change (YoY)	+5.06%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.01%
Owned by Institutions (%)	0.02%
Float	23.86M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.07
PB Ratio	0.67
P/TBV Ratio	0.91
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-3.27
EV / Sales	2.04
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-21.28

Financial Position

The company has a current ratio of 0.30, with a Debt / Equity ratio of 0.75.

Current Ratio	0.30
Quick Ratio	0.21
Debt / Equity	0.75
Debt / EBITDA	10.77
Debt / FCF	-12.50
Interest Coverage	-0.00

Financial Efficiency

Return on equity (ROE) is -32.41% and return on invested capital (ROIC) is -0.00%.

Return on Equity (ROE)	-32.41%
Return on Assets (ROA)	-0.00%
Return on Invested Capital (ROIC)	-0.00%
Return on Capital Employed (ROCE)	-0.00%
Revenue Per Employee	325.52M
Profits Per Employee	-203.19M
Employee Count	126
Asset Turnover	0.29
Inventory Turnover	6.25

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -78.16% in the last 52 weeks. The beta is 0.87, so KOSDAQ:200230's price volatility has been lower than the market average.

Beta (5Y)	0.87
52-Week Price Change	-78.16%
50-Day Moving Average	1,549.75
200-Day Moving Average	3,438.00
Relative Strength Index (RSI)	51.22
Average Volume (20 Days)	3,741,365

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KOSDAQ:200230 had revenue of KRW 41.02 billion and -25.60 billion in losses. Loss per share was -710.15.

Revenue	41.02B
Gross Profit	10.11B
Operating Income	-1.75M
Pretax Income	-25.61B
Net Income	-25.60B
EBITDA	4.56B
EBIT	-1.75M
Loss Per Share	-710.15

Balance Sheet

The company has 9.53 billion in cash and 49.13 billion in debt, giving a net cash position of -39.60 billion or -1,098.52 per share.

Cash & Cash Equivalents	9.53B
Total Debt	49.13B
Net Cash	-39.60B
Net Cash Per Share	-1,098.52
Equity (Book Value)	65.61B
Book Value Per Share	1,812.00
Working Capital	-46.80B

Cash Flow

In the last 12 months, operating cash flow was -973.12 million and capital expenditures -2.96 billion, giving a free cash flow of -3.93 billion.

Operating Cash Flow	-973.12M
Capital Expenditures	-2.96B
Free Cash Flow	-3.93B
FCF Per Share	-109.03

Margins

Gross margin is 24.65%, with operating and profit margins of -0.00% and -62.42%.

Gross Margin	24.65%
Operating Margin	-0.00%
Pretax Margin	-62.43%
Profit Margin	-62.42%
EBITDA Margin	11.12%
EBIT Margin	-0.00%
FCF Margin	n/a

Dividends & Yields

KOSDAQ:200230 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-5.06%
Shareholder Yield	-5.06%
Earnings Yield	-58.55%
FCF Yield	-8.99%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 22, 2025. It was a forward split with a ratio of 3.

Last Split Date	Aug 22, 2025
Split Type	Forward
Split Ratio	3

Scores

KOSDAQ:200230 has an Altman Z-Score of -1.63 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.63
Piotroski F-Score	2